Cagent
Success Details
GO PHILLY INVESTMENT
$1.5M | Fund ISECTOR
ITDATE INVESTED
2020FOUNDED
2012-
Website
Cagent Vascular is dedicated to improving the treatment of atherosclerotic cardiovascular disease, the leading cause of mortality and poor quality of life worldwide. The company’s vision is to be the leader for treating atherosclerotic disease with the first and only serration balloon technology to restore blood flow.